Company Summary
Quarterly Performance
Revenue
Operating Margin
Market Sentiment
※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate
Financials
Excel
No financial data is available for this period.
~
Quarterly
Annual
*Values beyond the fourth decimal place of the unit are displayed as '0/-0'
Financial Indicator Forecast
※ These forecasts are simple AI estimates
based on historical data and may differ from actual results.
Company Overview
as of March 2026
NEXTBIOMEDICAL Co., Ltd. is an innovative bio-solutions company that develops therapeutic materials based on polymer and drug delivery system technology; since its establishment in 2014, it has developed products reflecting the needs of clinical settings, such as endoscopic hemostatic materials and vascular embolization microspheres, and has had its technological and innovative capabilities recognized through domestic approvals and new medical technology designations as well as U.S. FDA and European CE certifications. Centered on CEO Lee Don-haeng, who has more than 30 years of clinical research and development experience, the company has research personnel capable of handling the entire process from development to commercialization, including R&D and translational research, clinical development, licensing, commercialization, and technology transfer, and it also has specialized personnel such as design history file and licensing experts and nonclinical testing staff capable of conducting its own efficacy evaluations to quickly commercialize its technologies.
Representative Director
Lee Donhaeng
Founded
August 1, 2014
Corporation Type
KOSDAQ
Industry Classification
Manufacture of other medical and surgical equipment and orthopedic appliances n.e.c.
Corporate number
12011-0720228
Business number
131-86-63415
Phone Number
032-454-4800
Fax Number
032-454-4811
Website
www.nextbiomedical.co.kr
Company Address
6 Venture-ro 100beon-gil, Yeonsu-gu, Incheon
Products & Services
Comments